MEDSCI: 2024 INTERIM REPORT

HKEXSep 27 16:32 · Announcements

Mesoblast (02415.HK): Cheng Liang appointed as executive director.

On September 25, Guolonghui announced that starting from September 25, 2024: (i) Fan Jie has resigned from the position of executive director; (ii) Hu Xubo has resigned from the position of non-executive director; (iii) Cheng Liang has been appointed as an executive director; (iv) Wang Xin has been appointed as a non-executive director.

Gelonghui FinanceSep 25 22:20

MedSci Healthcare Trustee Purchases Shares

MT NewswiresSep 16 18:55

MedSci Healthcare Advances Share Award Scheme

TipRanksSep 12 21:11

Meihs-kang (02415): The trustee purchased a total of 100,000 shares under the stock incentive plan.

Mei's Health (02415) announced that on September 11, 2024, the trustee purchased a total of 10 shares from the Hong Kong Stock Exchange.

Zhitong FinanceSep 12 20:40

The Stock Exchange of Shanghai and the Stock Exchange of Shenzhen: 33 shares will be included in the Hong Kong Stock Connect symbol from today.

The Shanghai Stock Exchange and Shenzhen Stock Exchange have announced that 33 stocks have been included in the list of Hong Kong stocks eligible for trading through the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect starting today.

AASTOCKSSep 10 10:09